html5-img
1 / 8

Sofosbuvir + Ribavirin in HCV Recurrence Following Liver Transplantation

Phase 2. Liver Transplantation. Treatment Naïve and Treatment Experienced. Sofosbuvir + Ribavirin in HCV Recurrence Following Liver Transplantation. Charlton MR, et al. Gastroenterology. 2014 Oct 7. [ Epub Ahead of Print]. Sofosbuvir + Ribavirin in Recurrent HCV Post Liver Transplant.

gersemi-hannes
Download Presentation

Sofosbuvir + Ribavirin in HCV Recurrence Following Liver Transplantation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Phase 2 Liver Transplantation Treatment Naïve and Treatment Experienced Sofosbuvir + Ribavirin in HCV Recurrence Following Liver Transplantation Charlton MR, et al. Gastroenterology. 2014 Oct 7. [Epub Ahead of Print]

  2. Sofosbuvir + Ribavirin in Recurrent HCV Post Liver Transplant Source: Charlton MR, et al. Gastroenterology. 2014 Oct 7. [Epub Ahead of Print]

  3. Sofosbuvir + Ribavirin in Recurrent HCV Post Liver Transplant Source: Charlton MR, et al. Gastroenterology. 2014 Oct 7. [Epub Ahead of Print]

  4. Sofosbuvir + Ribavirin in Recurrent HCV Post Liver TransplantDesign 0 24 36 Week SVR12 Drug DosingSofosbuvir: 400 mg once dailyRibavirin: administered in two divided daily doses (started at 400 mg/day and increased up to 1200 mg/day based on hemoglobin, creatinine clearance, and weight) Sofosbuvir + Ribavirin N = 40 Source: Charlton MR, et al. Gastroenterology. 2014 Oct 7. [Epub Ahead of Print]

  5. Sofosbuvir + Ribavirin in Recurrent HCV Post Liver TransplantResults 40/40 29/40 28/40 28/40 Source: Charlton MR, et al. Gastroenterology. 2014 Oct 7. [Epub Ahead of Print]

  6. Sofosbuvir + Ribavirin in Recurrent HCV Post Liver TransplantAdverse Effects Source: Charlton MR, et al. Gastroenterology. 2014 Oct 7. [Epub Ahead of Print]

  7. Sofosbuvir + Ribavirin in Recurrent HCV Post Liver TransplantConclusions Source: Charlton MR, et al. Gastroenterology. 2014 Oct 7. [Epub Ahead of Print]

  8. This slide deck is from the University of Washington’s Hepatitis C Online and Hepatitis Web Study projects. Hepatitis C Onlinewww.hepatitisc.uw.edu Hepatitis Web Studyhttp://depts.washington.edu/hepstudy/ Funded by a grant from the Centers for Disease Control and Prevention.

More Related